In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Merit Medical Systems (MMSI – Research Report), with a price target of $88.00. The company’s shares closed yesterday at $71.25.
According to TipRanks, Bednar is an analyst with an average return of -8.3% and a 37.09% success rate. Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Henry Schein, and DENTSPLY SIRONA.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Merit Medical Systems with a $84.00 average price target, which is a 17.89% upside from current levels. In a report released on December 15, Oppenheimer also maintained a Buy rating on the stock with a $82.00 price target.
See the top stocks recommended by analysts >>
The company has a one-year high of $85.62 and a one-year low of $62.58. Currently, Merit Medical Systems has an average volume of 427.4K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Merit Medical Systems (MMSI) Company Description:
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates advanced non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Read More on MMSI:
- Merit Medical Announces Process for Chief Executive Officer Succession Planning
- Merit Medical management to meet with Oppenheimer
- Merit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029
- Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes
- Merit Medical announces private placement of $550M convertible senior notes
